The primary rationale for coronary revascularization in ischemic cardiomyopathy is based on reducing chronic ischemia and restoring function in hibernating myocardium. There is a knowledge gap regarding the functional and clinical benefits of PCI in patients with ICM, particularly in relation to Myocardial viability assessment.
(2025). Impact of Revascularization Via PCI in Ischemic Cardiomyopathy on LV Function and Clinical Outcomes. Cardiovascular Research Prove Journal, 9(1), -. doi: 10.21608/cvrepj.2025.438164
MLA
. "Impact of Revascularization Via PCI in Ischemic Cardiomyopathy on LV Function and Clinical Outcomes", Cardiovascular Research Prove Journal, 9, 1, 2025, -. doi: 10.21608/cvrepj.2025.438164
HARVARD
(2025). 'Impact of Revascularization Via PCI in Ischemic Cardiomyopathy on LV Function and Clinical Outcomes', Cardiovascular Research Prove Journal, 9(1), pp. -. doi: 10.21608/cvrepj.2025.438164
VANCOUVER
Impact of Revascularization Via PCI in Ischemic Cardiomyopathy on LV Function and Clinical Outcomes. Cardiovascular Research Prove Journal, 2025; 9(1): -. doi: 10.21608/cvrepj.2025.438164
)
View on SCiNiTO